Home
About ArLAR
About Kuwait
Congress Venue
Hotel, Tours & Dinners
Information
ArLAR 25 Congress
Committees
ArLAR23 Kuwait Organizing Committee
ArLAR23 Kuwait Scientific Committee
ArLAR Executive Council
ArLAR Board Of Directors
ArLAR Scientific Committee
ArLAR Francophone Group
ArLAR PRAG Executive Board Committee
ArLAR Special Interest Groups – SIG
ArLAR23 Sessions
Program
Abstracts
Workshops
Speakers
Workshops Speakers
Sessions Speakers
Partners
Sponsors
Supporters
Registration
Promote
Arlar
Home
/
Abstract
/
Hip involvement and Wnt signaling pathway inhibitors in spondyloarthritis, is there a link?
Hip involvement and Wnt signaling pathway inhibitors in spondyloarthritis, is there a link?
admin
Does smoking impact serum Dickkopf1, Sclerostin, and Osteoprotegerin levels in patients with spondyloarthritis?
Previous post
ASSOCIATION OF ANTI-RIBOSOMAL-P ANTIBODIES WITH NEUROPSYCHIATRIC LUPUS IN SUDANESE PATIENTS ATTENDING RHEUMATOLOGY CLINIC IN OMDURMAN MILITARY HOSPITAL
Next post
admin
(Website)
administrator
This website is supported by
